BURLINGAME, Calif. — Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, and deepmirror, the AI drug design platform that empowers chemists to focus on more promising drug molecules, today announced a strategic partnership integrating deepmirror with CDD Vault to enhance drug discovery. CDD Vault helps research teams […]

Cambridge UK – Cresset, a leading provider of innovative solutions for the digitization of drug discovery, announces the acquisition of Molab.ai, a pioneer in artificial intelligence technologies tailored for molecular research. This strategic acquisition will combine Cresset’s powerful computational chemistry platform with Molab.ai’s proven capability to build highly predictive ADME models. It marks a significant […]

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK businesses on high […]

The research will focus on developing faster and more accurate methods for predicting drug metabolism CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project […]

INNOptimizer is using latest Bayesian Optimization algorithms and a broad set of analytical tools to guide optimizations with minimum experimentation needed. Don’t waste time and money with poor experimental design – use INNOptimizer™ to guide your experiments with state-of-the art Bayesian Optimization algorythms.”— Oliver May (GM Synsilico)GELEEN, LIMBURG, NETHERLANDS, July 2, 2025 /EINPresswire.com/ — SynSilico, […]

Mumbai, India – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and a wholly owned subsidiary of PI Industries, today announced a strategic collaboration with Cresset® to implement Torx® Software, a state-of-the-art cloud-based platform for small molecule drug discovery. This partnership marks a significant step in PI Health Sciences’ […]

Paris – Iktos, a leading provider of artificial intelligence solutions for drug discovery, is pleased to announce it has become an Advanced Technology Partner in the AWS Partner Network and joined the AWS ISV (Independent Software Vendor) Accelerate co-sell program. As part of this collaboration, Iktos has made Makya, its innovative de novo drug design […]

Investment demonstrates confidence in America’s commitment to science and innovation WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of […]

The collaboration aims to provide advanced resources and scientific expertise to accelerate innovation and drive sustainable growth SINGAPORE — Thermo Fisher Scientific Inc, the world leader in serving science, has signed a strategic Memorandum of Understanding with NSG BIO, Singapore’s largest BSL-2-certified, co-working laboratory and office space. This collaboration aims to empower biotech startups in Singapore with access to […]

Albert’s AI-enabled platform transforms materials science R&D and accelerates chemical innovation OAKLAND, Calif. — Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This […]